Themis Medicare Limited

Themis Chemicals Limited

Shashikant Prabhudas Kurani

Dinesh Shantilal Patel

Sachin Dinesh Patel

Madhavlal Govindlal Patel

Madhavlal Glovindlal Patel

Shachin Dinesh Patel

The present invention relates to pharmaceutical compositions of various pharmaceutical actives, especially lyophilic and hydrophilic actives containing Diethylene glycol monoethyl ether or other alkyl derivatives thereof as a primary vehicle and/or to pharmaceutical compositions utilizing Diethylene glycol monoethyl ether or other alkyl derivatives thereof as a primary vehicle or as a solvent system in preparation of such pharmaceutical compositions. The pharmaceutical compositions of the present invention are safe, non-toxic, exhibits enhanced physical stability compared to conventional formulations containing such pharmaceutical actives and are suitable for use as injectables for intravenous and intramuscular administration, as well as for use as a preformed solution/liquid for filling in and preparation of capsules, tablets, nasal sprays, gargles, dermal applications, gels, topicals, liquid oral dosage forms and other dosage forms.

Compositions of pharmaceutical actives containing diethylene glycol monoethyl ether or other alkyl derivatives

Preparation of selective cyclooxygenase II inhibitors

This invention relates to a novel pharmaceutical composition which may be administered parenterally to a mammal for the production of general anaesthesia, specifically to a limpid, stable, injectable pharmaceutical formulation of 2,6-diisopropylphenol. The formulation comprises 2,6-diisopropylphenol, a compound of the following general formula (I) ##STR1## wherein R.sub.1 and R.sub.2 can be the same or different and are hydrogen or lower alkyl group containing 1-3 carbons or acetate group and optionally water and/or one or more antioxidants.

Limpid parenteral solution of 2,6-diisoprophylphenol as an anaesthetic

Growing community of inventors

Mumbai, India

Shashikant Prabhudas Kurani